Viridian Therapeutics
VRDN
VRDN
105 hedge funds and large institutions have $778M invested in Viridian Therapeutics in 2022 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 51 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
67% more funds holding in top 10
Funds holding in top 10: 6 → 10 (+4)
25% more funds holding
Funds holding: 84 → 105 (+21)
1.73% less ownership
Funds ownership: 101.4% → 99.68% (-1.7%)
Holders
105
Holding in Top 10
10
Calls
$3.62M
Puts
$652K
Top Buyers
| 1 | +$21.7M | |
| 2 | +$20.5M | |
| 3 | +$18M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$16.4M |
| 5 |
State Street
Boston,
Massachusetts
|
+$14.8M |
Top Sellers
| 1 | -$16.8M | |
| 2 | -$11.3M | |
| 3 | -$10.3M | |
| 4 |
Millennium Management
New York
|
-$7.47M |
| 5 |
ABG
Ally Bridge Group
New York
|
-$5.74M |